Latest Breaking News On - Human genome sciences - Page 14 : comparemela.com

Codagenix Appoints Linda Maldonado as VP, Biologics Chemistry and Manufacturing Controls Ms. Maldonado to Oversee Manufacturing Development of Codagenix s Vaccines as Clinical Trials for COVID-19, RSV and Flu Progress News provided by Share this article Share this article FARMINGDALE, N.Y., April 14, 2021 /PRNewswire/  Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the appointment of biotech industry veteran Linda Maldonado as Vice President, Biologics Chemistry and Manufacturing Controls (CMC). We are pleased to welcome Linda to Codagenix s growing management team in anticipation of multiple significant growth opportunities this year, including the advancement COVI-VAC, our single-dose, intranasal, live-attenuated COVID-19 vaccine, to late-stage clinical trials, said J. Robert Coleman, Ph.D., CEO of Codagenix. Linda has a proven track record with clinical process development, scale-u

Sanofi pasteurBaxter bioscienceJohanna bennett ingrid mezoRobert colemanEckard wimmer at stony brook universityHuman genome sciencesBloomsburg universityStroudsburg universityNational academy of scienceCodagenix incLinda maldonadoVice presidentBiologics chemistryManufacturing controlsSynthetic attenuated virus engineeringSenior director